Please see the attached briefing note. This topic will be discussed at the April SNOMED CT Editorial Advisory Group and CMAG meetings. Comments prior to support the discussion at the meetings would be very welcome.
Relevant documents
| Date | Requested action | Requester(s) | Response required by: | Comments |
|---|---|---|---|---|
| 23 March 2022 | Review and comment As raised on the April CMAG meeting please post comments by 25 April 2022. | Please post your comments in the Country response table below. |
Initial Country Comments
Table to be completed by each CMAG member for their country. Please note as per the TOR responsibilities consideration needs to be given to Member countries who are not represented on this group to ensure that their priorities are reflected in the group discussions. Where a second round of review occurs, this table may be duplicated.
| Country | Date | Response |
|---|---|---|
| USA | 23MAR2022 | Proposal seems reasonable and will provide consistency across SNOMED CT findings. No specific comments or reservations. |
| Australia | 20220427 | We have no specific objections to the proposal. |
| Ireland | 27042022 |
From a haematology perspective I am unclear on the last concept on a measurement or level that is abnormal and on that basis am unclear as to whether accept or reject this final concept proposal. |
| Member countries without a CMAG rep |
The action taken by the IHTSDO, Advisory Group or other as relevant. This may be a written summary or link to the relevant Confluence page.